As part of the complex treatment of neuralgia, radiculitis, neuritis, which is accompanied by pain ; bronchial asthma, arthritis, polyarthritis, chronic inflammatory processes.
Main active ingredients: 1 ml of the preparation contains an extract of donor blood, plasma of native and erythrocyte mass, or extract of plasma of native and erythrocyte mass.
Excipients: sodium chloride, water for injection (included in the extract).
The resulting solution is a clear, colorless or slightly yellowish liquid with a specific odor. Light opalescence is allowed. The pH of the solution should be 6.0 – 7.0.
The drug is available in packages of 1 ml in an ampoule; 10 ampoules in a pack.
This drug belongs to the means that affect the digestive system and metabolic processes.
The active substance belongs to stimulants of biogenic origin, which show their activity in living organisms under certain conditions. This stimulant manifests its activity when it gets into conditions that require immediate adaptation. The drug exhibits a pronounced non-specific desensitizing (capable of inhibiting and preventing allergic reactions of various types in direct contact with the allergen) and analgesic (analgesic) effects. In addition, the drug has the ability to counteract inflammation in the body.
The specified pharmacological preparation is a product of the processing of donor blood, which is placed in special media in order to obtain an active component with the specified biological activity.
The drug Plazmol is prescribed as part of the complex treatment of the following diseases:
- neuritis, the course of which is accompanied by pain syndrome;
- bronchial asthma;
- chronic inflammatory processes.
The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.
The drug is contraindicated in the following cases:
- decompensated cardiac activity;
- autoimmune processes.
When prescribing the drug, it is contraindicated to prescribe physiotherapeutic procedures, such as quartz, solux, diathermy.
The drug is not used in pediatrics.
Application during pregnancy and lactation
This drug is not allowed to be used by pregnant women – only under strict indications determined by the attending physician.
If it is necessary to take the drug during breastfeeding, lactation is suspended.
Method of administration and dosage
Plazmol is administered subcutaneously to adults, 1 ml daily or every other day. The course of treatment is 10 injections.
Overdose cases were not recorded.
The drug is usually well tolerated when used in the recommended doses.
The following disorders can be observed as side effects:
- increased body temperature;
- general weakness;
- changes at the injection site.
Storage conditions and periods
Expiration date – up to 2 years from the production date indicated on the package. Storage periods should not be exceeded.
The storage temperature should be between 2 ° C and 8 ° C. Temperature deviations can change the properties of the preparation, therefore it should always be stored in its original packaging.